Research Article
Case Report
Review
Aim & Scope
The New Journal of Urology (New J Urol) is a scientific, referred, open access publication of the Eurasian Urooncological Association. The society is a non-profit organization and it aims to increase the standards in the field of urology including education of the academicians, professionals and public. The society also aims to create or make contributions for the development of technical, scientific and social facilities and it also cooperates with any and all related institutions, organizations, foundations and societies from the national and international area for this purpose.
The journal' s financial expenses are covered by the Eurasian Urooncological Association. The journal is published quarterly – three times a year- in February, June and October, respectively and the language of the journal is Turkish and English.
The purpose of the New Journal of Urology is to contribute to the literature by publishing urological manuscripts such as scientific articles, reviews, letters to the editor, case reports, reports of surgical techniques, surgical history, ethics, surgical education and articles of forensic medicine.
The target group of the journal consists of academicians working in the field of urology, urologists, residents of urology and all other fields of expertise and practitioners interested in urology.
Urology specialists, medical specialty fellows and other specialists who are interested in the field of urology are the journal’s target audience.
The New Journal of Urology is currently indexed by TUBITAK ULAKBIM-TR Directory, Google Schoolar, Index Copernicus, Scilit, TurkMedline (National Health Sciences-Periodicals Database), Turkish Citation Index, SOBIAD Citation Index, OAJI, İdeal Online, EuroPub, J-GATE, DOAJ, EBSCO, and InfoBase Index.
The journal is integrated with ORCID and CrosReff DOI.
All published content is available for free at https://dergipark.org.tr/en/pub/yud.
All manuscripts submitted to the journal should be submitted through the online application system avaible at https://dergipark.org.tr/tr/pub/yud
Instructions for authors including technical information and required forms can be found at the journal's website https://dergipark.org.tr/en/pub/yud/writing-rules
Editorial and publication processes of the journal are shaped in accordance with the guidelines of the international organizations such as the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE). The journal is in conformity with Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).
The statements and/ or opinions indicated at the articles which are published at the journal reflect the views of the author, not the opinions of the editors, editorial board and / or the publisher of the Eurasian Uroncological Association; Editors and publishers do not accept any responsibility for such materials.
No fee is required for submitting articles, evaluation, processing or publishing process from the authors.
The Eurasian Uroncological Association has national and international copyright to all content published in the journal.
The journal is printed on an acid-free paper.
Editor-in-Chief
Ali İhsan Taşçı, Department of Urology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
e-mail : aliihsantasci@hotmail.com
Editor
Yavuz Onur Danacıoğlu, Department of Urology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
e-mail: dr_yonur@hotmail.com
Associate Editor
Mithat Ekşi, Department of Urology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
e-mail: mithat_eksi@hotmail.com
Author Guidelines
AUTHOR GUIDELINES
Information About Journal
The New Journal of Urology (New J Urol) is the journal published by Eurasian Urooncological Association. The New Journal of Urology is an international, scientific, open access, online/published journal in accordance with independent, unbiased, and double-blinded peer-review principles, published three times a year on February, June and October. New J Urol is indexing in both international and national indexes and the publication language is English. New J Urol is indexing in both international and national indexes; TUBITAK ULAKBIM-TR Directory, Google Schoolar, Index Copernicus, Scilit, TurkMedline (National Health Sciences-Periodicals Database), Turkish Citation Index, SOBIAD Citation Index, OAJI, İdeal Online, EuroPub, J-GATE, DOAJ, EBSCO, and InfoBase Index.
The New Journal of Urology publishes papers on all aspects of urology and related topics. In addition to original articles, review articles, case reports and letters to the editor are also published. The scientific board guiding the selection of the papers to be published in the journal consists of elected experts of the journal and if necessary, are selected from national and international authorities.
The authors should guarantee that the manuscripts have not been previously published and/or are under consideration for publication elsewhere. Only those data presented at scientific meetings in form of an abstract may be accepted for consideration, however, the date, name and place of the meeting in which the paper was presented should be stated. The signed statement of scientific contributions and responsibilities of all authors, and statement on the absence of conflict of interests are required. All manuscripts are reviewed by the editor and at least two experts/reviewers. The authors of the accepted for publication manuscripts should agree that the editor can make corrections on the condition that there are no changes in the main text of the paper. Manuscript format should be in accordance with Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (available at http://www.icmje.org/). The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE). The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing.
The New Journal of Urology does not charge any article submission or processing fee.
All submissions are screened by a similarity detection software (iThenticate by Crossref). In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, and data falsification/fabrication, the Editorial Board will follow and act in accordance with COPE guidelines.
As of 2021, only articles in English will be considered for publication.
The authors should identify the individuals who accept direct responsibility for the manuscript. Each individual listed as an author should fully meet the criteria for authorship and should complete an authorship form (criteria recommended by the International Committee of Medical Journal Editors - www.icmje.org/). The corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Authors' credentials and e-mail addresses are in no way used for other purposes. The journal will allow the authors to retain publishing rights without restrictions.
When using previously published content, including figures, tables, or any other material in electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).
Statements or opinions expressed in the manuscripts published in The New Journal of Urology reflect the views of the author(s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility regarding the published content rests with the authors.
General Guidelines
Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system, available at https://dergipark.org.tr/en/yud. Manuscripts submitted via any other medium will not be evaluated. Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript has been prepared and submitted in accordance with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be returned to the submitting author with technical correction requests. The editor reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. Editors have the right to make corrections without changing the main text.
The ORCID (Open Researcher and Contributor ID) number of the authors should be provided while sending the manuscript. A free registration can be done at http://orcid.org.
For the experimental, clinical and drug studies having the obligation of being approved by ethical committee and being sent to be published in The New Journal of Urology, ethical committee approval report being in accordance with the international agreements is required (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). In experimental animal studies, the authors should indicate that the procedures followed were in accordance with animal rights ("Guide for the Care and Use of Laboratory Animals" https://oacu.oir.nih.gov/regulations-standards) and they should obtain animal ethics committee approval. The approval of the ethical committee including the approval number and the fact that the “informed consent” is given by the patients should be indicated in the “Methods” section. Authors should declare the conflict of interest concerning their articles and the financial supports.
The rules for the title page, references, figures and tables are valid for all types of articles published in this journal.
Authors are required to submit the following:
• Author Contribution&Copyright Transfer Form
• Informed Consent Form
• ICMJE Disclosure of Interest
• Title Page
• Main document
• Figures
• Tables
PREPARATION OF MANUSCRIPT
Title Page
A separate title page should include the full title of the manuscript, running title, author’s name, affiliations, ORCID ID of authors, corresponding author’s contact information. The author to whom correspondence will be addressed should be indicated (email address, address, telephone and fax numbers).
If the content of the paper has been presented before, and if the summary has been published, the time and place of the conference should be denoted on this page.
If any grants or other financial support has been given by any institutions or firms for the study, information must be provided by the authors.
Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfill the authorship criteria should be included.
Main Document
The articles should be written with double-spaced in 12-point, Times New Roman character and at least 2.5 cm from all edges of each page. The main text should not contain any information about the authors' names and affiliations. On the first page (both Turkish and English) title, abstract and keywords should be given.
Abstract
Original articles should have a structured English (Objective, Material and Methods, Results, Conclusion) and Turkish (Amaç, Gereç ve Yöntemler, Bulgular, Sonuç) abstract. Review articles and case reports should have an unstructured abstract. Articles and abstracts should be written in accordance with the word limits specified in the table. References, tables and citations should not be used in an abstract.
Keywords
Authors must include relevant keywords (3-6) on the line following the end of the abstract The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html).
For the international authors, submission of Turkish title, Turkish abstracts and Turkish keywords are not required. These will be provided by the editorial office.
Manuscript
All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be explained clearly in parentheses following the definition and custom abbreviations should not be used.
Statistical analysis is usually necessary to support results in original articles. Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and the statistical software that was used during the process must be specified.
Whenever a product, software, or software program is mentioned in the main text, product information (including state in the USA) must be given in parentheses, including the product name, product manufacturer, city of production, and country of the company.
Limitations, drawbacks, and the shortcomings of original articles should be mentioned in the discussion section before the conclusion paragraph.
Reviews prepared by authors who have extensive knowledge on a particular field and whose scientific background has been translated into a high volume of publications with a high citation potential are welcomed. These authors may even be invited by the journal. Reviews should describe, discuss, and evaluate the current level of knowledge of a topic in clinical practice and should guide future studies.
Letter to the Editor discusses important parts, overlooked aspects, or lacking parts of a previously published article. Articles on subjects within the scope of the journal that might attract the readers’ attention, particularly educative cases, may also be submitted in the form of a “Letter to the Editor.” Readers can also present their comments on the published manuscripts in the form of a “Letter to the Editor.” The text should be unstructured.
All references, tables, and figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text. The symbols used must be nomenclature used standards.
All pages of the manuscript should be numbered at the bottom center, except for the title page. Papers should include the necessary number of tables and figures to provide better understanding.
Limitations for each manuscript type
| Type of Article | Abstract word limit | Word limit | References limit | Table limit | Figure limit |
| Original Article | 250 (Structured) | 3000 | 30 | 6 | 5 |
| Review Article | 250 (Unstructured) | 4000 | 50 | 6 | 6 |
| Case Reports | 250 (Unstructured) | 2000 | 10 | 1 | 3 |
| Letter to the Editor | No abstract | 1000 | 5 | 1 | 1 |
Original Research Articles should include subheadings below;
• Title (both Turkish and English)
• Abstract (both Turkish and English)
• Keywords (both Turkish and English)
• Introduction
• Material and Methods
• Results
• Discussion
• Conclusions
• Figures and Tables Legend
• References
Case Reports should include subheadings below;
• Title (both Turkish and English)
• Abstract (unstructured, both Turkish and English)
• Keywords (both Turkish and English)
• Introduction
• Case Presentation
• Discussion and Conclusion
• Figures and Tables Legend
• References
Review Article should include subheadings below;
• Title (both Turkish and English)
• Abstract (unstructured, both Turkish and English)
• Keywords (both Turkish and English)
• Main text
• Conclusion
• Figures and Tables Legend
• References
For systematic reviews, authors must adhere to the PRISMA guidelines (http://www.prisma-statement.org/documents/PRISMA%202009%20checklist.pdf).
Letters to Editor should include subheadings below;
• Title
• Keywords
• Main text
• Figures and Table Legend
• References
Figures and Tables
Figures, graphics, and photographs should be submitted as separate files (in JPEG format) through the submission system.
The files should not be embedded in a Word file of the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system.
Images should be numbered by Arabic numbers to indicate figure subunits.
Thick and thin arrows, arrowheads, stars, asterisks, and similar marks can be used on the images to support figure legends.
The minimum resolution of each submitted figure should be 300 DPI.
Figures or illustrations must not permit the identification of patients and written informed consent for publication must be sought for any photograph.
Figure legends should be listed at the end of the main document.
Tables should embed in the main document or should be submitted as separate files but if tables are submitted separately please note where it is suitable in the main text. All tables should be numbered consecutively in the order they are used to within the main text. Tables legends should be listed at the end of the main document.
References
While citing publications, preference should be given to the latest, most up-to-date publications. Authors should avoid using references that are older than ten years. The references used in the article must be written in parenthesis, at the end of the sentences. References should be numbered in the order they appear in the text and listed in the same order in which they are cited in the text. Be consistent with your referencing style across the document.
References must contain surnames and initials of all authors, article title, name of the journal, the year, and the first and last page numbers. If there are more than 6 authors, an abbreviation of “et al.” should be used for the authors out of the first three. Journal titles should be abbreviated according to Index Medicus.
You must add the DOI (Digital object identifier) at end of each reference.
For Examples
Article in journal: Tasci A, Tugcu V, Ozbay B, et al. Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia. J Endourol. 2009;23:1879-1881.
For Books: Günalp İ. Modern Üroloji. Ankara: Yargıçoğlu Matbaası, 1975.
Chapters in books: Anderson JL, Muhlestein JB. Extra corporeal ureteric stenting during laparoscopic pyeloplasty. Philadelphia: W.B. Saunders, 2003; p. 288-307.
For website; Gaudin S. How moon landing changed technology history [serial online]. 2009 [cited 2014 June 15]. Available from: http://www.computerworlduk.com/in-depth/it-business/2387/how-moon-landing-changed-technology-history/
For conference proceeding; Anderson JC. Current status of chorion villus biopsy. Paper presented at: APSB 1986. Proceedings of the 4th Congress of the Australian Perinatal Society, Mothers and Babies; 1986 Sep 8-10; Queensland, Australian. Berlin: Springer; 1986. p. 182-191.
For Thesis; Ercan S. Venöz yetmezlikli hastalarda kalf kası egzersizlerinin venöz fonksiyona ve kas gücüne etkisi. Süleyman Demirel Üniversitesi Tıp Fakültesi Spor Hekimliği Anabilim Dalı Uzmanlık Tezi. Isparta: Süleyman Demirel Üniversitesi; 2016.
Author Contribution&Copyright Transfer Form
The New Journal of Urology requires corresponding authors to submit a signed and scanned version of the authorship contribution form (available for download through https://dergipark.org.tr/tr/journal/1455/file/2260/download) during the initial submission process to act appropriately on authorship rights and to prevent ghost or honorary authorship.
Manuscript Retraction: For any other reason authors may withdraw their manuscript from the journal with a written declaration.
Revisions
When submitting a revised version of a paper, the author must submit a detailed “Response to the reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment, followed by the author’s reply and line numbers where the changes have been made) as well as an annotated copy of the main document. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be canceled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial period is over.
AFTER ACCEPTANCE
Accepted manuscripts are copy-edited for grammar, punctuation, and format. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested. The journal owner and the editorial board are authorized to decide in which volume of the accepted article will be printed. Authors may publish their articles on their personal or corporate websites by linking them to the appropriate cite and library rules.
Ethical Principles and Publication Policy
Instructions for authors are shaped on the recommendations of International Committee of Medical Journal Editors
The Editorial Board Members of the Journal accept to follow 'Editorial Policy' of the 'Council of Science Editors' and the guidelines provided by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE) for dealing with scientific misconduct, such as falsification of data, plagiarism, improprieties of authorship, violation of generally accepted research practices and redundant publication and duplicate publication.
Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.
An approval of research protocols by the Ethics Committee in accordance with international agreements World Medical Association Declaration of Helsinki is required for experimental, clinical, and drug studies and for some case reports. If required, ethics committee reports or an equivalent official document will be requested from the authors.
If there is any concern or dispute at over the stıdies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them.
Price Policy
The New Journal of Urology does not charge any article submission or processing fee.
Indexes
Journal Boards
Auto-generated board - Please Edit This Title
1985 yılında İstanbul’da doğan Doç. Dr. Yavuz Onur Danacıoğlu, Bülent Ecevit Üniversitesi Tıp Fakültesi bölümünden 2010 yılında mezun olarak tıp eğitimini tamamlamıştır. Üroloji ihtisasını 2018 yılında Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesi’nde başarıyla tamamlayarak Üroloji Uzmanı unvanını almıştır.
İhtisas süresi içinde 2014 yılında Amerika Birleşik Devletleri Cornell Üniversitesinde Androloji deneyimlerini artırmak için bir süre görev almıştır. Ulusal ve merkezi yapılan sınavı başarıyla geçerek Türk Üroloji Yeterlilik Sertifikası almaya hak kazanmış. Ardından uluslararası olarak gerçekleştirilen Avrupa Üroloji Board yeterlilik sınavını başarıyla geçerek FEBU ünvanı almaya hak kazanmıştır.
Mecburi hizmetini Ağrı Devlet Hastanesi’nde Üroloji Uzmanı olarak yapmış, kariyerine Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi’nde devam etmiş ve burada 2022 yılında Doçent unvanını almıştır. Aynı hastanede, Sağlık Bilimleri Üniversitesi Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi Üroloji Kliniği Eğitim Görevlisi olarak çalışmaktadır. Uzmanlık sonrasında ki yıllarda çalışmalarını özellikle Androloji, Endo-üroloji, Üro-onkoloji, Nöroüroloji ve Rekonstrüktif üroloji üzerine yoğunlaştırmıştır. Mesleki yaşantısı; ürolojinin tüm alanları ile yoğun ilgilenerek ve bu alanlardaki her türden pek çok zorlu cerrahi müdahalelere katılarak geçmiştir.
Ulusal ve Uluslararası hakemli dergilerde 140'dan fazla makale ve 9 kitap bölümü yayımlayan Danacıoğlu’nun çalışmaları 418 kez atıf almıştır. Bilimsel başarıları, en iyi video ve en iyi poster ödülleri ile uluslararası kongrelerde takdir edilmiştir. Üroloji alanında Türkiye’nin önde gelen bilimsel dergilerinden biri olan The New Journal of Urology Dergisi’nde Editörlük görevini sürdürmektedir.
Doç. Dr. Yavuz Onur Danacıoğlu, mesleki kariyerinde edindiği bilgi ve tecrübelerle hastalarına en üst düzeyde sağlık hizmeti sunmayı amaçlamaktadır. Yenilikçi tedavi yöntemleri konusundaki uzmanlığı ile tanınan Doç. Dr. Danacıoğlu, hastalarına modern ve etkili çözümler sunmaktadır.
2- Yayınlar
BİLİMSEL KURULUŞLARA ÜYELİKLER
TÜRK ÜROLOJİ DERNEĞİ
TÜRK ENDOÜROLOJİ DERNEĞİ
TÜRK ANDROLOJİ DERNEĞİ
AVRASYA ÜROONKOLOJİ DERNEĞİ
ÖDÜLLER ve SERTİFİKALAR
· Araştırma planlaması ve İstatistiksel Değerlendirme, 2015
· Türk Üroloji Yeterlilik Belgesi, 2016
· Deney Hayvanları Kullanım Sertifikası, 2016
· Avrupa Üroloji Yeterlilik Belgesi, 2017
· Da Vinci System Training First Assistant, 2018
· 5. İstanbul Ürolitiyazis Günleri En iyi Poster Ödülü - 2017
· 33. Avrupa Üroloji Kongresi En iyi Poster Ödülü – 2018
· 9. Avrasya Üroonkoloji Kongresi En İyi İkinci Sözlü Sunum Ödülü – 2019
· 39. SIU kongresi En iyi Poster Ödülü – 2019
· 28. Ulusal Üroloji Kongresi En İyi Üçüncü Bildiri Ödülü – 2019
· AcademicGeriatricsAssociation E-Congress En iyi Bildiri Ödülü- 2020
· Çocuk Üroloji Kongresi En iyi Sözlü Bildiri Üçüncülük Ödülü - 2021
GÖREV ALINAN KURS EĞİTMENLİKLERİ
1.KURS EĞİTMENİ
1 E 1 YERİNDE CANLI PERİNEOSKOPİK ÜRETROPLASTİ KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, KURS, 07.02.2020 -07.02.2020 (ULUSAL)
2. KURS EĞİTMENİ
ENDOÜROLOJİ DERNEĞİ 1 E 1 YERİNDE CANLI SUPİN PCNL (ECIRS) KURSU BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 14.02.2020 -14.02.2020 (ULUSAL)
3. KURS EĞİTMENİ
TÜRK ÜROLOJİ AKADEMİSİ 1 E 1 YERİNDE CANLI ÜRETROPLASTİ KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 27.12.2019 -27.12.2019 (ULUSAL)
4. KURS EĞİTMENİ
1 E 1 YERİNDE CANLI PERİNEOSKOPİK ÜRETROPLASTİ KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 12.12.2019 -13.12.2019 (ULUSAL)
5. KURS EĞİTMENİ
1 E 1 YERİNDE CANLI PERİNEAL RADİKAL PROSTATEKTOMİ KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 22.11.2019 -22.11.2019 (ULUSAL)
6. KURS EĞİTMENİ
ENDOÜROLOJİ DERNEĞİ 1 E 1 YERİNDE CANLI ECIRS KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 24.05.2019 -24.05.2019 (ULUSAL)
BİLİMSEL DERGİ ve KİTAPLARDAKİ EDİTÖRLÜK
· The New Journal of Urology, Editörlük, 2023 – Halen
· Androloji Bülteni, Yardımcı Editörlük, 2025 – Halen
· Avrupa Üroloji CepKılavuzu,Türk Üroloji Derneği Yayınları, Çeviri editörlüğü, 2024
· International Journal of Clinical Urology, Danışma Kurulu, 2022 – Halen
TIPTA UZMANLIK TEZİ:
İnterstisyel sistit hayvan modelinde intravezikal hyalüronik asit, kondroitin sülfat ve hyalüronik asit-kondroitin sülfat kombinasyon tedavilerinin karşılaştırılması
ULUSLARARASI HAKEMLİ DERGİLERDE YAYIMLANAN MAKALELER
1- The cost analysis of flexible ureteroscopic lithotripsy in 302 cases. Gurbuz C, Atış G, Arikan O, Efilioglu O, Yıldırım A, Danacıoglu O, Caskurlu T. Urolit; 2014 42: 155-158
2- Comparison of combined antioxidants and thymoquinone in the prevention of testis ischemia - reperfusion injury. Erol B, Sari U, Amasyali AS, Ozkanli S, Sogut S, Hanci V, Efiloglu O, Danacıoglu YO, Engin P, Yencilek F, Atis G, Yildirim A, Alkoc OA, Caskurlu T. Andorology; 2017 5:119-124
3- Bladder Cancer and Genetic Polymorphisms: A Review.Erol B, Ulus I, Danacıoglu YO, Caskurlu T.European Medical Journal Urology 2015 3: 20-25
4- Prevelance of antibiotic resistance in fecal flora before transrectal ultrasound-guided prostate biopsy and the clinical impact of targeted antibiotic prophylaxis. Arikan O, Yildirim A, Atis G, Berrin T, Gurbuz C, Erol B, Danacioglu Y.O, Culpan M, Vahapoglu H, Caskurlu H, Caskurlu T. Arch Esp Urol 2017 70(10):858-858.
5- Can intervals in extracorporeal shock wave lithotripsy sessions affect success in the treatment of upper ureteral stones? Turan T, Efiloglu O, Danacioglu Y.O, Sendogan F, Culpan M, Gunaydın B, Atıs R.G, Caskurlu T, Yildirim A. Videosurgery and Other Miniinvasive Techniques/Wideochirurgia i inne techniki małoinwazyjne. 2018. doi:10.5114/wiitm.2018.75873.
6- The Fate of Residual Fragments After Retrograde Intrarenal Surgery in Long-Term Follow-up. Atis, G., Pelit, E. S., Culpan, M., Gunaydin, B., Turan, T., Danacioglu, Y. O.,Yildirim A, Caskurlu, T. UrolJ doi:10.22037/uj.v0i0.4124
7- Reasons for early readmission after percutaneous nephrolithotomy and retrograde intrarenal surgery. Keskin S.K, Danacioglu Y.O, Turan T., Atis R.G., Canakci C, Caskurlu T, Erol A, Yildirim A. Videosurgery and Other Miniinvasive Techniques doi:10.5114/wiitm.2018.77705
8- Laparoscopy versus robotic assisted pyeloplasty in children: preliminary results of a pilot prospective randomized controlled trial.Sılay M.S, Danacioglu Y.O, Ozel K, Karaman M.İ, Caskurlu T. World Journal of Urology doi: 10.1007/s00345-019-02910-8
9- Re:Laparoscopic transposition of lower-pole crossing vessels: Long-termfollow-upof33patientsatpuberty.SilayM.S,DanaciogluY.O,Caskurlu T.Journal ofpediatricurology12.6(2016): 1
10- The effects of intradetrusor BoNT-A injections on vesicoureteral reflux in children with myelodysplasia. “Toprak T., Danacioglu Y.O., Verit A. International Neurourology J 23.4 (2019) doi: 10.5213/inj.1938100.050
11- Does duration of stenting increase the risk of clinical infection?.Toprak T,,Sahin Aytac, Kutluhan M, Akgul K, Danacioglu Y.O. et al. Archivio ItalianodiUrologiaeAndrologia91.4 (2019):237-240 doi: 10.4081/aiua.2019.4.237
12- Evaluation of factors affecting sexualdysfunction in female patients with diabetes mellitus.Yenice M.G,Danacioglu Y.O. et al. Archives of endocrinology and metabolism 64 (2020):319-325doi:10.20945/2359-3997000000238
13- A nationwide survey on the impact of COVID‐19 pandemic on minimalinvasive surgery in urology practice. Danacioglu Y.O, Soytas M., Polat S.,, Ozdemir O., Arikan O., Yenice M.G, Atis R.G, TasciA.İ International Journal of Clinical Practice (2021): e14309 doi:10.1111/ijcp.14309
14- Effect of focal and diffuse hypervascularization as cystoscopic findings on predicting intravesical therapy response in patients with bladder pain syndrome. Erol B., Danacioglu Y.O. et al. Turkish J of Urol. 47.4 (2021) doi: 10.5152/tju.2021.21093
15- Thepresenceofchronicinflammationin positiveprostatebiopsy isassociatedwithupgradinginradicalprostatectomy."Guner E,DanaciogluY.O,etal. Archivio Italiano di Urologia e Andrologia 93.3 (2021): 280-284 doi:10.4081/aiua.2021.3.280
16- Perioperative myocardial damage and theincidence of type 2 myocardial infarction in patients with intermediate andhigh cardiovascular risk. Keskinler M.V., Köstek O., Erok B., Telci Ö.,DanaciogluY.O., OğuzA.AnatolianJournalof Cardiology25.2(2021):89 doi:10.14744/AnatolJCardiol.2020.45752
17- Female Urethroplasty with dorsal onlay labia minora graft: Technical details and initial results. Simsek A., Danacioglu Y.O. et al. Female Pelvic Medicine & Reconstructive Surgery 27.9 (2021): 560-563 doi:10.1097/SPV.00000000000976
18- Current advances in neuromodulation techniques in urology practices: A review of literature.” Bulent E., Danacioglu Y.O., Kenneth M. Peters. Turkish J of Urol 47.5 (2021): 375-385 doi: 10.5152/tud.2021.21152
19- Comparisonoftwodifferentgraftsforthesurgicaltreatmentofpeyronie’sdisease." Danacıoğlu, Yavuz Onur, Colakoglu Y., Yenice M.G., Keser F., Simsek A., Erol B. Andrologia 53.3 (2021): e13987.doi:10.1111/and.13987
20- Perineoscopic vesicourethral reconstruction: A novel surgical technique for anastomotic stricture following radical prostatectomy. Simsek A., Danacioglu Y.O. et al. Turkish J of Urol 47.1 (2021) doi: 10.5152/tud.2020.20372
21- Management of post-circumcision necrosis of the penis: themedicolegal aspect. Tasci A.İ, Danacioglu Y.O et al. Pediatric surgeryinternational 36.4 (2020): 523-528.
22- The efficiency of prostate-specific antigen density measurement using threedifferent methods on the prediction of biochemical recurrence." DanaciogluY.O, Keser F., Efiloglu O., Culpan M., Polat S., Atıs R.G., Yıldırım A. The Aging Male 24.1 (2021): 15-23.
23- Relationship between the types of urinary incontinence, handgrip strength, and pelvic floor muscle strength in adult women. Soytas R.B, Soytas M., Danacioglu Y.O. et al. Neurourology and Urodynamics 40 (6) (2021): 1532 doi: 10.1000/nau.24699
24- The effects of shock wave lithotripsy and retrograde intrarenal surgery onrenal function."Turan T., Danacioglu Y.O et al. Minimally Invasive Therapy&Allied Technologies(2020): 1-6
25- Testicular torsion in the medicolegal perspective: Why is the diagnosismissing?.TasciA.İ,DanaciogluY.Oetal. TurkishJournalofTraumaandEmergencySurgery 27.2(2021): 207-213
26- Comparison of Intravesical Hyaluronic Acid, Chondroitin Sulfate, and Combination of Hyaluronic Acid-Chondroitin Sulfate Therapies in Animal Model of Interstitial Cystitis.Danacioglu Y.O, Erol B., Ozkanlı S., Yıldırım A., Atıs R.G., Silay M.S., Caskurlu T. Int Neurourol J 25.1 (2021) 42. Doi: 10.5213/inj.1938176.088
27- External validation of the TO HO. score and derivation of the modified TOHO. score for predicting stone-free status after flexible ureteroscopy inureteral and renal stones." Polat S., Danacioglu Y.O. , Soytas M., Yarimoglu S., Koras O., Fakir A.E., Seker K.G., Degirmenci T. Int J Clin Pract (2021):e14653. Doi: 10.1111/ijcp.14653
28- Factorspredictingdurationandsuccessofsemirigidureteroscopy forureteralstones in different localizations." Guner E., Danacioglu Y.O et al. ArchivosEspanolesdeUrologia 74.3 (2021): 335-342
29- Factors predicting the successof intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort. Danacioglu Y.O, Keser F., Ersoz C., Polat S., Avci A.E., Kalkan S., Silay M.S. Journal of Pediatric Urology (2021), 17 (4) P520.E1-520.E7 Doi:10.1016/j.jpurol.2021.02.020
30- Thepresenceofchronicinflammationin positiveprostatebiopsy isassociatedwithupgradinginradicalprostatectomy."GunerE.,DanaciogluY.O.etal. Archivio ItalianodiUrologiaeAndrologia 93.3(2021):280-284. Doi: 10.4081/aiua.2021.3.280
31- Relationship of MRI-measured pelvimetric dimensions and surgical positions with anaesthesia parameters in robotic perineal prostatectomy. Yenice MG, Danacıoğlu Y.O., Akkaş F, Emir N.S., Şimşek A, Tuğcu V, Tasci A.İ. Arch Esp Urol. 2022 Jan;75(1):69-76. English, Spanish. PMID: 35173071.
32- COVID-19 and Urology: A bibliometric analysis of the literature” Soytas M.,Danacioglu Y.O. et al. International Journal of Clinical Practice Doi:10.1111/ijcp.14965
33- A novel model using computed tomography parameters to predict shock wave lithotripsy success in ureteral stones at different locations. Akkaş F, Culha MG, Ayten A, Danacıoğlu YO, Yildiz Ö, İnci E, Guner E, Şahin S. Actas Urol Esp 2022 Mar; 46:114-121. Doi: 10.1016/j.acuroe.2021.01.011.
34- Supine Percutaneous Nephrolithotomy in a Patient with Solitary Lung: A Case Report and Literature Review. Danacıoğlu YO, Arıkan Y, Akkaş F, Şam E, Özlü DN, Emir NS, Atar FA. Prague Med Rep. 2021;122:294-299. doi: 10.14712/23362936.2021.27. P.
35- Congenital megalourethra and posterior urethral valve in a patient with Down syndrome. Turk J Urol. 2019 Dec; 45:S181-S184. Danacıoğlu Y.O., Karaman M.I., Çaşkurlu T, Sılay M.S.Doi: 10.5152/tud.2018.70852. Epub 2018 Aug 28. PMID: 33120010
36- The optimal settings of holmium YAG laser in treatment of pediatric urolithiasis. Ersoz C., İlktac A., Dogan B., Kalkan S., Danacioglu Y.O., Sılay M.S. Lasers in Medical Science. 37.1 (2022): 317-321
37- Global Practice Patterns in the Evaluation of Non-Obstructive Azoospermia: Results of a World-Wide Survey and Expert Recommendations. Shah R., Danacioglu Y.O et al.World J Mens Health. 2024 Oct;42(4):727-748. Doi: 10.5534/wjmh.230333.
38- Global Andrology Forum. Global Practice Patterns and Variations in the Medical and Surgical Management of Non-Obstructive Azoospermia: Results of a World-Wide Survey, Guidelines and Expert Recommendations. World J Mens Health. Rambhalta A., Danacioglu Y.O. et al, 2024 Apr 4. Doi: 10.5534/wjmh.230339.
39- Analyzing learning curve for supine percutaneous nephrolithotomy in urology resident training programme: comparative analysis. Urolithiasis.Arıkan Y, Danacioğlu Y.O., Özlü D.N., Koraş Ö, Emir B, Keskin M.Z. 2024 9;1:129. Doi: 10.1007/s00240-024-0162
40- The prevalence and topographic distribution of penile calcification in a large cohort: a retrospective cross-sectional study. Int J Impot Res. Baran C., Danacioglu Y.O. et al., 2024 Sep;36(6):576-580. Doi: 10.1038/s41443-023-00758-6.
41- Controversy and Consensus on Indications for Sperm DNA Fragmentation Testing in Male Infertility: A Global Survey, Current Guidelines, and Expert Recommendations. World J Mens Health. Agarwal A., Danacioglu Y.O. et al., 2023 Jul;41(3):575-602. Doi: 10.5534/wjmh.220282.
42- Adaptation of the professionalism mini-evaluation exercise instrument into Turkish: a validity and reliability study. BMC Med Educ. Tasci A.İ., Akdeniz E., Gulpinar M.A., Danacioglu Y.O., Sari E.E., Yasar L., Karandere F., Ferahman S. 2023 Sep 26;23(1):698. Doi: 10.1186/s12909-023-04675-6.
43- The Predictive Factors of Renal Loss After Iatrogenic Ureteral Avulsion in the Medicolegal Perspective. Sisli Etfal Hastan Tip Bul. Tasci A.İ., Danacioglu Y.O., Akkas F., Polat S.,Arikan Y., Guner E., Atar F.A., Buyuk Y. 2023 Mar 21;57:92-98. Doi: 10.14744/SEMB.2022.92603.
44- A Critical Analysis of the Magnetic Resonance Imaging Lesion Diameter Threshold for Adverse Pathology Features. Prague Med Rep. Danacioglu Y.O., Turkay R., Yildiz O., Polat S., Arikan Y., Polat H., Yenice M.G., Baytekin H.F., İnci E., Tasci A.İ. 2023;124:40-51. Doi: 10.14712/23362936.2023.4
45- The Relationship Between Lymphocyte Subtypes with Clinicopathological Features and Prognosis of Prostate Cancer in Patients Undergoing Radical Prostatectomy. Urol Res Pract. Sendogan F., Danacioglu Y.O. et al. 2023 Jul;49:253-258. Doi: 10.5152/tud.2023.22220.
46- External validation of the current scoring systems and derivation of a novel scoring system to predict stone free rates after retrograde intrarenal surgery in patients with cumulative stone diameter of 2-4 cm. Actas Urol Esp. Polat S., Danacioglu Y.O., Yarimoglu Y., Soytas M., Erdogan A., Teke K., Degirmenci T., Tasci A.İ. 2023 May;47:211-220. Doi: 10.1016/j.acuroe.2022.08.015.
47- The role of penile elastography in the evaluation of erectile dysfunction in patients with chronic obstructive pulmonary disease. Cent European J Urol. Yenice M.G., Danacioglu Y.O. Turkay R., Tastan C.P., Artan E., Sam E., Simsek A., Tasci A.İ. 2022;75:96-101. Doi: 10.5173/ceju.2022.0238.
48- Assistant port is unnecessary for robotic-assisted laparoscopic pyeloplasty in children: a comparative cohort study. Pediatr Surg Int. Danacioglu Y.O., Keser F., Polat S. Gunaydın B., Comez Y.I., Silay M.S. 2022 389:1327-34. Doi: 10.1007/s00383-022-05158-3.
ULUSAL HAKEMLİ DERGİLERDE YAYIMLANAN MAKALELER
1- Benign Lesions Detected in Patients Undergoing Nephrectomy for Renal Mass: Single Center Experiences. Güner, E., Danacıoğlu, Y.O., Arıkan, Y., Ekşi, M., Şam, E., Hüseynov, J., Taşçı, A.İ..J Recons Urol, 2019, 9, 73-78. Doi: 10.5336/urology.2019-72133
2- The Current Approaches of Urologist in Treatment of Benign ProstateHyperplasia in Turkey." Sendogan F., Danacioglu Y.O et al. New J Urol 14, 105-113
3- Current Diagnosis, Treatment and Follow-up Procedures of ParatesticularMasses”. Yenice M.G., Danacioglu Y.O et al. New J Urol 15, 176-181
4- Thefrequencyof theincidental prostatecancer ofthepatientsthatwere diagnosedasbladdercancerandunderwentradicalcystectomyand the oncological outcomes." Turan T., Danacioglu Y.Oet al. New J Urol 2018: 13, 16-21
5- Predictive parameters on the effect of ofloxacin treatment on the reduction ofPSA in patients with elevated PSA level. Teke Kerem., Danacioglu Y.O.,Polat,S. New J Urol 14, 166-175.
6- Auxiliary tests in the diagnosis of prostate cancer." Medeniyet Med J.Danacioglu Y.Oet al. 2018:33, 47-53
7- PenileMondor'sDisease: ASeriesofThreeCasesandLiterature Review. J Recons Urol. Seker K., Danacioglu Y.O. et al.10, 98-102
8- The Risk Factors of Unplanned Hospital Readmission FollowingPercutaneousNephrolithotomy." Danacıoğlu Y.O Ozlu D.N., Akkas F., Yenice M.G., Tasci A.İ.JAREM.2021: 11.1 69. Doi: 10.4274/jarem.galenos.2021.3915
9- PSA Değeri 4, 0-10, 0 ng/mL Arasında Olan Hastalarda İlk Biyopsi ÖncesiELISA Yöntemi ile Elde Edilen [-2] ProPSA ve Türevlerinin Prostat KanseriTanısındaki Etkinliği." Yenice M.G., Danacioglu Y.O., et al. J Recons Urol 2019: 9, 100-104.
10-SarcomatoidCarcinoma,aVariantHistologyoftheBladder:CaseSeriesand Literature Review." Danacıoğlu Y.Oet al. New J Urol. 14:182-188.
11-Current approaches in incontinence after prostatectomy surgery: A review of literature” J Recons Urol. Danacioglu Y.O et al. 2019, 9: 25-33 Doi: 10.5336/urology.2019-66618
12-The genetic causes of infertility in patients with oligozoospermia andazoospermia in Turkish population. Danacıoğlu, Y.O, Yenice M.G., Akkas F., Soytas M., Seyhan S., Tasci A.İ. New J Urol2021:16,159-164. Doi: 10.33719/yud.2021;16-2-834672
13-The approach of emergency physicians to patients with acute renal colic. Bozan O., Danacıoğlu Y.O, İslam M.M. New J Urol 2022, 17, 44-51. Doi:10.33719/yud.2022;17-1-1016256
14-At what stage are we in active surveillance for localized prostate cancer? Our clinical experience. Evren İ., Danacioglu Y.O., Eksi M., Ozlu D.N., Haciislamoglu A., Arikan Y., Ayten A., Polat H. New J Urol 2023, 18, 8-15. Doi:10.33719/yud.2023;18-1-1129666
15-Predicting Factors for Lymph Node Metastasis in Anterior Prostatic Fat Tissue Excised During Radical Prostatectomy. Akkas F., Danacioglu Y.O., Yenice M.G., Şeker G., Şahin S. Harran Med J., 2020, 17, 289-293. Doi: 10.35440/hutfd.728011
16-Risk Factors Affecting Success of Urethroplasty in Male Patients – Single Center Results. Danacioglu Y.O., Sungur U., Akkas F., Birinci M., Soytas M., Simsek A. Harran Med J., 2021, 18, 410-416. Doi: 10.35440/hutfd.1007386
17-Factors That Affecting Success and Re-admission in the Treatment of Proximal Ureteral Stones with Shock Wave Lithotripsy. Toprak T., Kutluhan M.A., Danacıoğlu Y.O., Arıkan Y., Arslan U., Topaktas R. The Medical Journal Of Haydarpaşa Numune Training and Research Hospital, 2022, 62, 42-7. Doi: 10.14744/hnhj.2020.03064
18-Disseminated bacillus calmette-guérin (bcg) ınfection caused by ınadvertent ıntravenous ınfusion of bcg for the treatment of bladder cancer: case. Danacıoğlu Y.O., Turan T., Yıldırım A., Caskurlu T. Turkiye Klinikleri Journal of Case Reports, 2017, 25. 128-131. Doi: 10.5336/caserep.2017-55785
19-Relationship between the prostate cancer screening attitudes, beliefs, and knowledge levels of men working in a healthcare institution. Ozdemir İ.N., Calıskan F., Danacıoğlu Y.O.New J Urol, 2023, 18: 173-182. Doi: 10.33719/yud.2023;18-2-1270777
20-Case Report: Successful resection of a bladder leiomyoma causing lower urinary tract symptoms. Danacıoğlu Y.O., Erol B., Zerk P.E., Gucluer B., Yildirim A., Caskurlu T. New J Urol, 2018, 13:49-52. Doi:
21- Synchronous Tumors: Renal Cell Carcinoma with Adenocarcinoma of the Ampulla of Vater; Case Report. Danacioglu Y.O., Keser F., Zerk P.E., Simsek B., Turan T. Medeniyet Med J, 2019,34: 208-212. Doi: 10.5222/MMJ.2019.08784
22-Practice patterns of turkish urologists regarding ıntravesical botulinum toxin-a ınjections for overactive bladder and neurogenic lower urinary tract dysfunction: a survey study. Coskun B., Bayrak O., Corabay S., Tahra A., Karakeci A., Colakoglu Y., Danacıoğlu Y.O., Onem K. J Recons Urol, 2023, 13:67-75. Doi: 10.5336/urology.2023-98660
23-İnterstisyel sistit (mesane ağrı sendromu) farmakoterapisi, sınıflandırılması, karakterizasyonu ve alt gruplandırılması. Danacıoğlu Y.O., Simsek A. Kontinans ve Nöroüroloji Bülteni, 2021, 8:29-36.
24-İki Olgu Eşliğinde Mesane Sarkomatoid Karsinomu. Danacıoğlu Y.O., Aydın Abdullah., Turan T., Güçlüer B., Yıldırım A. Ürolojik Onkoloji Bülteni, 2018, 2:75-80
25-Prostat Kanseri Tanısında ve Prognoz Öngörüsünde Kullanılan Biyobelirteçler. Danacıoğlu Y.O., Yucetas U. Ürolojik Onkoloji Bülteni, 2019, 3:15-23
Kitap Bölümleri
1- Üreteroskopi Sonrası Sepsis Ölüm Nedeni midir?DanaciogluY.O,Atis
R.G.Tıp Hukuku2017 Sayfa156-160
2- Testis Tümörlerine Yaklaşım.DanaciogluY.O,Yucetas. U.Ürolojide Temel Yaklaşım ve Yönetim2019 Bölüm49 Sayfa 533-544
3- Üriner Sistem Taş Hastalığında ESWL'nin Son Durumu.Danacioglu Y.O,AtisR.G. Güncel Üroloji-2. 2018 Sayfa713-721
4- Adolesen varikosel.PolatS.,DanaciogluY.O.Sağlık Bilimleride Multidisipliner Yaklaşım 2020 Sayfa275-293
5- URS-RIRC.DanaciogluY.O,AtisR.G.Ürolojide Sık Kullanılan Deney Hayvan Modelleri 2020 Sayfa267-273
6- Renal İnfarkt. Danacioglu Y.O., Şahin S. Ürolojik Aciller 2022 Sayfa 133-144
7- GOSSİPİBOMA: Mutlak Bir İnsan Hatası mıdır? Olgu Sunumu ve Literatür Değerlendirilmesi. Danacioglu Y.O., Arikan Y. Ürolojik Vakalar, Tedaviler ve Literatürde Yaklaşım 2019Sayfa 25-35
8- İntravezikal Farmakoterapi ve İntravezikal Elektrostimulasyon. Danacioglu Y.O, Polat S. Nöroüroloji 2024 Sayfa 61-73
9- Abiraterone Acetate Therapy for Metastatic Prostate Cancer. Polat H., Danacioglu Y.O. Current management of metastatic prostate cancer. 2024 Sayfa 89-96
MİTHAT EKŞİ, M.D
Language: Turkish, English
E.mail: mithat_eksi@hotmail.com
Department of Urology, University of Health Sciences, Bakırköy Dr.Sadi Konuk Training and Research Hospital, Türkiye
EDUCATION
2007‐2013: Cerrahpaşa Faculty of Medicine, Istanbul University Medical Student
2013‐2018: Bakırköy Dr.Sadi Konuk Training and Research Hospitall Urology Resident
CLINICAL INTEREST
Urooncology, Minimally Invasive Surgery, Transplantation
PROFESSIONAL MEMBERSHIPS
European Association of Urology Turkish Journal of Urology Society of Urological Surgery
Editorial Board
Editor-in-Chief
Ali Ihsan TASCIDepartment of Urology, Dr.Sadi Konuk Training and Research Hospital, Istanbul/Türkiye
E-mail: aliihsantasci@hotmail.com
OORCID ID: https://orcid.org/0000-0002-6943-6676
Editor
Yavuz Onur DANACIOGLUDepartment of Urology, Dr.Sadi Konuk Training and Research Hospital, Istanbul/Türkiye
E-mail: dr_yonur@hotmail.com
ORCID ID: https://orcid.org/0000-0002-3170-062X
Deputy Editor-in-Chief
Mithat EKSIDepartment of Urology, Dr.Sadi Konuk Training and Research Hospital, Istanbul/Türkiye
E-mail: mithat_eksi@hotmail.com
ORCID ID: https://orcid.org/0000-0003-1490-3756
Biostatistical Editor
Salih POLATDepartment of Urology, Amasya University Sabuncuoglu Serefeddin Training and Research Hospital, Amasya/Türkiye
E-mail: salihpolat@gmail.com
ORCID ID: https://orcid.org/0000-0002-7580-6872
Language Editor
Serda GUZELDepartment of Translation and Interpreting, Istanbul Arel University, Istanbul/Türkiye
E-mail: serdaguzel@arel.edu.tr
ORCID ID: https://orcid.org/0000-0001-5212-9891
Digital Media Editor
Mustafa SOYTAŞClinical Fellow of Urooncology Division of Urology and Uro-oncology, McGill University Montreal, QC, CANADA
E-mail: drmustafasoytas@gmail.com
ORCID ID: https://orcid.org/0000-0002-3474-3510
Copy Editors
Murat SAHANDepartment of Urology, İzmir Bozyaka Training and Research Hospital, Izmir/Türkiye
E-mail: dr.msahan@gmail.com
ORCID ID: https://orcid.org/0000-0002-0065-4245
Samet SENEL
Department of Urology, Ankara City Hospital, Ankara/Türkiye
E-mail:samet_senel_umt@hotmail.com
ORCID ID: https://orcid.org/0000-0003-2280-4192
ADVISORY BOARD
Abdullah Erdem CANDADepartment of Urology, Faculty of Medicine, Koc University, Istanbul/Türkiye
E-mail: erdemcanda@yahoo.com
ORCID ID: https://orcid.org/0000-0002-5196-653X
Ahmet Rahmi ONUR
Department of Urology, Faculty of Medicine, Firat University, Elazig/Türkiye
E-mail: rahmionur@yahoo.com
ORCID ID: https://orcid.org/0000-0001-6235-0389
Ahmet Yaser MUSLUMANOGLU
Department of Urology, Bagcilar Training and Research Hospital, Istanbul/Türkiye
E-mail: ymuslumanoglu56@hotmail.com
ORCID ID: https://orcid.org/0000-0002-8691-0886
Ali Serdar GOZEN
Department of Urology, SLK Klinikum Heilbronn, Am Gesundbrunnen 20, Heilbronn, GERMANY
E-mail: asgozen@yahoo.com
ORCID ID: https://orcid.org/0000-0002-2205-5876
Arunas ZELVYS
European Association of Urology, European Board of Urology, Vilnius University Hospital Santariskiu Klinikos Vilnius, Lithuania
E-mail: arunas.zelvys@santa.It
ORCID ID: https://orcid.org/0000 0002 9778 9372
Asif YILDIRIM
Department of Urology, Goztepe Medeniyet University, Istanbul/Türkiye
E-mail: asifyildirim@yahoo.com
ORCID ID: https://orcid.org/0000-0002-3386-971X
Archil CHKHOTUA
L. Managadze National Center of Urology
E-mail: achkhotua@gmail.com
ORCID ID: https://orcid.org/0000-0002-0384-8619
Ates KADIOGLU
Department of Urology, Faculty of Medicine, Istanbul University, Istanbul/Türkiye
E-mail: kadiogluates@ttnet.net.tr
ORCID ID: https://orcid.org/0000-0002-5767-4837
Badrinath KONETY
Allina Health Cancer Institute – Minneapolis
E-mail: badrinath.konety@allina.com
ORCID ID: https://orcid.org/0000-0002-1088-3981
Fatih YANARAL
Department of Urology, Memorial Şişli Hospital, İstanbul/Türkiye
E-mail: fatihyanaral@gmail.com
ORCID ID: https://orcid.org/0000-0002-7395-541X
Hashim HASHİM
Bristol Urological Institute, Southmead Hospital, Bristol, Somerset, UK.
E-mail: h.hashim@gmail.com
ORCID ID: https://orcid.org/0000-0003-2467-407X
Ihsan KARAMAN
Department of Urology, Medistate Kavacik Hospital, Istanbul/Türkiye
E-mail: mikaraman@hotmail.com
ORCID ID: https://orcid.org/0000-0003-3275-3202
Imad ZIOUZIOU
Department of Urology, College of Medicine and Pharmacy, Ibn Zohr University, Agadir, Morocco
E-mail: ımadzıouzıou@hotmaıl.com
ORCID ID: https://orcid.org/0000-0002-9844-6080
Jean De La ROSETTA
Department of Urology, Istanbul Medipol University, Istanbul/Türkiye
E-mail: jdelarosette@medipol.edu.tr
ORCID ID: https://orcid.org/0000-0002-6308-1763
Jeremy Y. C. TEOH
MBBS, FRCSEd (Urol), FCSHK, FHKAM (Surgery).
Prince of Wales Hospital, Shatin, Hong Kong.
E-mail: jeremyteoh@surgery.cuhk.edu.hk
ORCID ID: https://orcid.org/0000-0002-9361-2342
Joyce BAARD
Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
E-mail: j.baard@amsterdamumc.nl
ORCID ID: https://orcid.org/0000-0002-5509-0213
Kemal SARICA
Department of Urology, Kafkas University, Kars/Türkiye
E-mail: kemalsarica@superonline.com
ORCID ID: https://orcid.org/0000-0001-7277-3764
M. Derya BALBAY
Department of Urology, Şişli Memorial Hospital, Istanbul/Türkiye
E-mail: derya.balbay@memorial.com.tr
ORCID ID: https://orcid.org/0000-0003-0060-5491
Mahmut GUMUS
Department of Medical Oncology, Faculty of Medicine, Medeniyet University, Istanbul/Türkiye
E-mail: mahmut.gumus@medeniyet.edu.tr
ORCID ID: https://orcid.org/0000-0003-3550-9993
Mesrur Selcuk SILAY
Department of Urology, Bahcelievler Memorial Hospital, Istanbul/Türkiye
E-mail: selcuksilay@gmail.com
ORCID ID: https://orcid.org/0000-0001-5091-9654
Mohammed SAID SULAIMAN
Department of Surgery, St. Paul’s Hospital Millennium Medical College, Addis Ababa, Jigjiga /Ethiopia
E-mail: bensulaimani@gmail.com
ORCID ID: https://orcid.org/0009-0007-2879-3048
Murat BOZLU
Department of Urology, Faculty of Medicine, Mersin University, Mersin/Türkiye
E-mail: muratbozlu@yahoo.com
ORCID ID: https://orcid.org/0000-0002-8624-0149
Oner SANLI
Department of Urology, Faculty of Medicine, Istanbul University, Istanbul/Türkiye
E-mail: onersanli@hotmail.com
ORCID ID: https://orcid.org/0000-0001-5801-6898
Osama Kamal ZAKİ SHAEER
Faculty of Medicine, Cairo University, Egypt
Email: dr.osama@alrijal.com
ORCID ID: https://orcid.org/0000-0002-3811-9969
Paolo GONTERO
Urology Unit, Department of Surgical Sciences, University of Turin, Italy
E-mail: paolo.gontero@unito.it
ORCID ID: https://orcid.org/0000-0002-9714-6596
Pilar LAGUNA
Department of Urology, Istanbul Medipol University, Istanbul/Türkiye
E-mail: plaguna@medipol.edu.tr
ORCID ID: https://orcid.org/0000-0003-0906-4417
Ramazan Gökhan ATIŞ
Department of Urology, Memorial Şişli Hospital, Istanbul/Türkiye
E-mail: gokhanatis@hotmail.com
ORCID ID: https://orcid.org/0000-0002-9065-6104
Rajveer PUROHIT
Department of Urology, Mount Sinai Hospital, New York/USA
E-mail: rajveer.purohit@mountsinai.org
ORCID ID: https://orcid.org/0000-0002-5912-8354
Raed AZHAR
Urology Department of King Abdulaziz University Saudi Arabia Kingdom
E-mail: raedazhar@gmail.com
ORCID ID: https://orcid.org/0000-0001-5233-1352
Saad ALDOUSARI
Department of Surgery of Kuwait University KUWAIT
E-mail: saad.aldousari@gmail.com
ORCID ID: https://orcid.org/0000-0003-1670-9287
Selami ALBAYRAK
Department of Urology, Faculty of Medicine, Medipol University, Istanbul/Türkiye
E-mail: salbayrak@medipol.edu.tr
ORCID ID: https://orcid.org/0000-0002-4245-7506
Shahid KHAN
Department of Urology, East Surrey Hospital, London/United Kingdom
E-mail: shahidkhan1@nhs.net
ORCID ID: https://orcid.org/0009-0002-3072-1514
Sudhır KUMAR RAWAL
MBBS, MS, M.CH, D.N.B (UROLOGY)
Medical Director and Chief of GenitoUro - Oncology Services
Rajiv Gandhi Cancer Institute,
E-mail: sunil.kumar@amo.bbott.com
ORCID ID: https://orcid.org/0000-0002-3331-2372
Simon TANGUAY
FRCSC Professor and Chair Division of Urology Mostafa Elhilali/David Azrieli Chair in Urologic Sciences McGill University
E-mail: simon.tanguay@mcgill.ca
ORCID ID: https://orcid.org/0000-0001-6947-304X
Turhan ÇAŞKURLU
Department of Urology, Memorial Ataşehir Hospital Istanbul/Türkiye
E-mail: tcaskurlu@hotmail.com
ORCID ID: https://orcid.org/0000-0002-4471-2670
Volkan TUGCU
Department of Urology, Liv Hospital, Istanbul/Türkiye
E-mail: volantugcu@yahoo.com
ORCID ID: https://orcid.org/0000-0002-4136-7584
Yodgorov Ibrokhim FAKHRIDDINOVICH
Bukhara state medical university. Bukhara, Özbekistan
E-mail: ibroxim_yodgorov@mail.ru
ORCID ID: https://orcid.org/ 0000-0001-9563-0686
Widi ATMOKO
Department of Urology, Cipto Mangunkusumo General Hospital, Universitas Indonesia, Indonesia
E-mail: dr.widiatmoko@yahoo.com
ORCID ID: https://orcid.org/0000-0002-7793-7083
Editorial Advisory Board
Abdullah Erdem CANDA
Department of Urology, Faculty of Medicine, Koc University, Istanbul/TURKEY
Abdurrahim IMAMOGLU
Department of Urology, Diskapi Yildirim Beyazit Training and Research Hospital, Altindag, Ankara/TURKEY
Adem FAZLİOGLU
Department of Urology, Gaziosmanpasa Hospital, Gaziosmanpasa, İstanbul/TURKEY
Ahmet Rahmi ONUR
Department of Urology, Faculty of Medicine, Marmara University, Istanbul/TURKEY
Ahmet SOYLU
Department of Urology, Gozde Academy Hospital, Malatya/TURKEY
Ahmet Yaser MUSLUMANOGLU
Department of Urology, Bagcilar Training and Research Hospital, Bagcilar, Istanbul//TURKEY
Ali ATAN
Department of Urology, Faculty of Medicine, Gazi University, Yenimahalle, Ankara/TURKEY
Ali Fuat ATMACA
Department of Urology, Ataturk Training and Research Hospital, Cankaya, Ankara/TURKEY
Alim KOSAR
Department of Urology, Faculty of Medicine, Suleyman Demirel University, Ankara/TURKEY
Ali Serdar GOZEN
Department of Urology, SLK Klinikum Heilbronn, Am Gesundbrunnen 20, HEİLBRONN, GERMANY
Ali UNSAL
Department of Urology, Faculty of Medicine, Gazi University, Yenimahalle, Ankara/TURKEY
Arslan ARDICOGLU
Department of Urology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara/TURKEY
Asif YILDIRIM
Department of Urology, Goztepe Medeniyet University, Kadikoy, Istanbul/TURKEY
Ates KADIOGLU
Department of Urology, Faculty of Medicine, İstanbul University, Istanbul/TURKEY
Atilla
SEMERCIOZ
Department of Urology, Bagcilar Training and Research Hospital, Bagcilar, Istanbul/TURKEY
Ayhan VERIT
Department of Urology, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul/TURKEY
Azam DEMIREL
Department of Urology, Faculty of Medicine, Ataturk University, Erzurum/TURKEY
Baris ALTAY
Department of Urology, Faculty of Medicine, Ege University, Bornova, Izmir/TURKEY
Baris NUHOGLU
Department of Urology, Gaziosmanpasa Training and Research Hospital Gaziosmanpasa, Istanbul/TURKEY
Bulent
ERKURT
Department of Urology, Faculty of Medicine, Medipol University, Istanbul/TURKEY
Bulent EROL
Department of Urology, Faculty of Medicine, Medeniyet University, Istanbul/TURKEY
Cankon GERMIYANOGLU
Department of Urology, Faculty of Medicine, Ondokuz Mayis University, Samsun/TURKEY
Cenk GURBUZ
Department of Urology, Goztepe Training and Research Hospital, Medeniyet University, Kadikoy / Istanbul/TURKEY
Cetin
DİNCEL
Department of Urology, Bozyaka Training and Research Hospital, Izmir/TURKEY
Dogan UNAL
Department of Urology, Faculty of Medicine, Hacettepe University, Ankara/TURKEY
Emrah YURUK
Department of Urology, Bagcilar Training and Research Hospital, Bagcilar / Istanbul/TURKEY
Enver OZDEMIR
Department of Urology, Gaziosmanpasa Taksim Training and Research Hospital, Istanbul/TURKEY
Eyup
GUMUS
Department of Urology, Umraniye Training and Research Hospital, Umraniye, Istanbul/TURKEY
Eyup Veli KUCUK
Department of Urology, Haydarpasa Numune Hospital, Uskudar, Istanbul/TURKEY
Faruk
YENCILEK
Department of Urology, Faculty of Medicine, Yeditepe University, Atasehir, Istanbul/TURKEY
Fatih ALTUNRENDE
Department of Urology, Okmeydani Training and Research Hospital, Okmeydani, Istanbul/TURKEY
Gokhan
ATIS
Department of Urology, Goztepe Training and Research Hospital, Medeniyet University, Kadikoy, Istanbul/TURKEY
Halil
CIFTCI
Department of Urology, Faculty of Medicine, Harran University, Sanliurfa/TURKEY
Haluk EROL
Department of Urology, Faculty of Medicine, Adnan Menderes University, Aydin/TURKEY
Ibrahim
Yasar OZGOK
Department of Urology, Gulhane Training and Research Hospital, Etlik, Ankara/TURKEY
Ihsan KARAMAN
Department of Urology, Medistate Kavacik Hospital, Istanbul/TURKEY
Ilhan GECIT
Department of Urology, Faculty of Medicine, Yuzuncu Yil University, Van/TURKEY
Ilker SECKİNER
Department of Urology, Faculty of Medicine, Gaziantep University, Gaziantep/TURKEY
Irfan ORHAN
Department of Urology, Faculty of Medicine, Firat University, Elazig/TURKEY
Kemal
SARICA
Department of Urology, Lutfi Kirdar Training and Research Hospital, Kartal, Istanbul/TURKEY
M. Derya BALBAY
Department of Urology, Memorial Hospital, Sisli, Istanbul/TURKEY
M. Kemal ATILLA
Department of Urology, Samsun Training and Research Hospital, Samsun/TURKEY
Mahmut GUMUS
Department of Medical Oncology, Faculty of Medicine, Medeniyet University Kadikoy, Istanbul/TURKEY
Mehmet Giray SONMEZ
Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Meram, Konya/TURKEY
Mesrur
Selcuk SILAY
Department of Urology, Memorial Hospital, Bahcelievler, Istanbul/TURKEY
Metin OZTURK
Department of Urology, Haydarpasa Numune Hospital, Istanbul/TURKEY
Metin SEVUK
Department of Urology, Faculty of Medicine, Akdeniz University, Antalya
Murat BOZLU
Department of Urology, Faculty of Medicine, Mersin University, Yenisehir, Mersin/TURKEY
Murat Can KIREMIT
Department of Urology, Hospital of Koc University, Topkapi, Istanbul/TURKEY
Oktay
AKCA
Department of Urology, Lutfi Kirdar Training and Research Hospital, Kartal, Istanbul/TURKEY
Orhan KOCA
Department of Urology, Haseki Training and Research Hospital, Fatih, Istanbul/TURKEY
Oner ODABAS
Department of Urology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara/TURKEY
Oner SANLI
Department of Urology, Faculty of Medicine, Istanbul University, Capa, Istanbul/TURKEY
Ozcan ATAHAN
Medical Park Bursa Hospital, Department of Urology, Bursa/TURKEY
Ozdal DILLIOGLUGIL
Department of Urology, Faculty of Medicine, Kocaeli University, Kocaeli/TURKEY
Ozkan POLAT
Department of Urology, Faculty of Medicine, Ataturk University, Erzurum/TURKEY
Rahim HORUZ
Department of Urology, Faculty of Medicine, Medipol University, Istanbul/TURKEY
Recai GURBUZ
Department of Urology, Faculty of Medicine, Bezmialem University, Fatih, Istanbul/TURKEY
Sabahattin AYDIN
Department of Urology, Faculty of Medicine, Medipol University, Istanbul/TURKEY
Sefa RESIM
Department of Urology, Faculty of Medicine, Kahramanmaras Sutcu İmam University, Kahramanmaras/TURKEY
Selami ALBAYRAK
Department of Urology, Faculty of Medicine, Medipol University, Istanbul/TURKEY
Selcuk SAHİN
Department of Urology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Bakirkoy, Istanbul/TURKEY
Serkan ALTINOVA
Department of Urology, Ankara Liv Hospital, Cankaya, Ankara/TURKEY
Tarkan SOYGUR
Department of Urology, Faculty of Medicine, Ankara University, Ankara/TURKEY
Turgut YAPANOGLU
Department of Urology, Faculty of Medicine, Ataturk University, Erzurum/TURKEY
Turhan CASKURLU
Department of Urology, Goztepe Training and Research Hospital, Medeniyet University, Istanbul/TURKEY
Tzevat TEVFIK
Department of Urology, Faculty of Medicine, Istanbul University, Capa, Istanbul/TURKEY
Ugur BALCI
Department of Urology, Ataturk Training and Research Hospital, Katip Celebi University, Izmir/TURKEY
Ugur BOYLU
Department of Urology, Umraniye Education and Research Hospital, Umraniye, Istanbul/TURKEY
Volkan TUGCU
Department of Urology, Memorial Hospital, Bahcelievler, Istanbul/TURKEY
Yigit
AKIN
Department of Urology, Faculty of Medicine, Erzincan University, Erzincan/TURKEY
Yunus SOYLET
Department of Urology, Acibadem Fulya Hospital, Besiktas Istanbul/TURKEY
Yusuf Ozlem ILBEY
Department of Urology, İzmir Tepecik Training and Research Hospital, Konak, Izmir/TURKEY
Yuksel YILMAZ
Department of Urology, Ataturk Training and and Research Hospital, Katip Celebi University, Izmir/TURKEY
